home / stock / canf / canf quote
Last: | $2.2374 |
---|---|
Change Percent: | -1.95% |
Open: | $2.09 |
Close: | $2.2374 |
High: | $2.24 |
Low: | $2.04 |
Volume: | 26,727 |
Last Trade Date Time: | 05/16/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$2.2374 | $2.09 | $2.2374 | $2.24 | $2.04 | 26,727 | 05-16-2024 |
$2.05 | $2.13 | $2.05 | $2.23 | $2.05 | 6,646 | 05-15-2024 |
$2.13 | $2.1 | $2.13 | $2.175 | $2.09 | 8,655 | 05-14-2024 |
$2.135 | $2.08 | $2.135 | $2.15 | $2.08 | 13,257 | 05-13-2024 |
$2.09 | $2.12 | $2.09 | $2.12 | $2.0525 | 9,250 | 05-10-2024 |
$2.1418 | $2.15 | $2.1418 | $2.2 | $2 | 150,476 | 05-09-2024 |
$2.02 | $2.0701 | $2.02 | $2.14 | $2.02 | 5,296 | 05-08-2024 |
$2.07 | $2.15 | $2.07 | $2.15 | $2.07 | 15,852 | 05-07-2024 |
$2.11 | $2.32 | $2.11 | $2.32 | $2.11 | 20,955 | 05-06-2024 |
$2.09 | $2.1 | $2.09 | $2.15 | $2 | 3,218 | 05-03-2024 |
$2.03 | $2.09 | $2.03 | $2.21 | $2.01 | 10,925 | 05-02-2024 |
$2.09 | $2.12 | $2.09 | $2.12 | $2.0001 | 27,382 | 05-01-2024 |
$2.07 | $2 | $2.07 | $2.25 | $2 | 45,491 | 04-30-2024 |
$1.97 | $1.98 | $1.97 | $2.02 | $1.95 | 8,739 | 04-29-2024 |
$1.98 | $2 | $1.98 | $2.01 | $1.91 | 8,665 | 04-26-2024 |
$1.92 | $1.94 | $1.92 | $1.9703 | $1.91 | 12,346 | 04-25-2024 |
$1.94 | $1.96 | $1.94 | $1.96 | $1.93 | 5,741 | 04-24-2024 |
$1.97 | $1.9601 | $1.97 | $1.9759 | $1.96 | 3,761 | 04-23-2024 |
$1.98 | $2 | $1.98 | $2.05 | $1.91 | 8,684 | 04-22-2024 |
$1.98 | $1.96 | $1.98 | $2.07 | $1.96 | 7,822 | 04-19-2024 |
News, Short Squeeze, Breakout and More Instantly...
Can-Fite Biopharma Ltd Sponsored ADR Company Name:
CANF Stock Symbol:
NYSE Market:
Can-Fite has received agreement from both the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) on the current pivotal Phase 3 clinical study Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CANF), a biotechnology company advancing a pipeline of proprietar...
ORLANDO, FL / ACCESSWIRE / May 10, 2024 / RedChip Companies will air interviews with Can-Fite BioPharma Ltd. (NYSE American:CANF) and Nutriband Inc. (NASDAQ:NTRB) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV, this Saturday, May 11, at 7 p.m. Eastern ...
Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CANF), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncological and inflammatory diseases, today announces that the U.S. Food and Drug Administration (FDA) has granted Investigational New Drug (IN...